Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
about
Dilated cardiomyopathy associated with chronic overuse of an adrenaline inhalerThe pathophysiology and clinical aspects of hypercalcemic disorders.Medical management of hypercalcaemia.Hypocalcemic tetany following hypertonic phosphate enemas.The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. IHypercalcemia and cancer: an updateAdverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.A family with massive acute vitamin D intoxication.Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTHA case of acute hyperparathyroidism, with thyrotoxicosis and pancreatitis, presenting as hyperemesis gravidarum.An acceptable slow-release phosphate preparation "slow P"Can features of phosphate toxicity appear in normophosphatemia?Hypercalcemia in the Intensive Care Unit: A Review of Pathophysiology, Diagnosis, and Modern Therapy.Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection.Studies of the mechanism by which phosphate infusion lowers serum calcium concentration.Normal pressure hydrocephalus: did publications alter management?Phosphate treatment of hypercalcemia.Pseudohypoparathyroidism with raised plasma alkaline phosphatase.Recurrent ventricular arrhythmias complicating myocardial infarction in the presence of phaeochromocytoma.Microvascular thrombosis of the bowel in paroxysmal nocturnal haemoglobinuria.Comparison of latex and haemolysin tests for determination of anti-streptolysin O (ASO) antibodies.Hypercalcemia and malignant disease in the elderly: magnesium sulphate therapy.Drugs for the treatment of hypercalcaemia.Skull radiology in patients with psychiatric illness.Retrospective chart evaluation of hypercalcemia management in oncology patients at the University of Chicago Medical Center.Diagnosis and treatment of hypercalcaemia.
P2860
Q28316591-F0F6969E-40BD-4F2A-ACF3-5211AF28069EQ34052040-EF61101F-9382-4A9E-8DDA-1D33B72AA9C7Q34403106-B45FDC41-C87C-45D2-BABB-4E958E97368CQ34515668-2FCE9855-9290-4951-8A1C-0DDE37857719Q34769668-573B3ADC-B9BB-4370-89E7-D8A9B993853CQ35674357-D7C33F20-1706-4E59-9FDF-294774C03F82Q36063298-F20FEAD2-4DE8-45E1-9D4E-B33B50381BB0Q36715914-9CDF8D5A-C525-4C6E-83C0-89AD5BD7DFA6Q36762546-8C6890A1-0091-4772-A427-B94384691278Q36770901-AE51E2C8-8E8C-4BDF-B780-CC9449924BF7Q36771636-9B176220-EC01-46CE-8392-DD559E5181D6Q37244863-A6D18F20-AF79-409A-A006-9AC72E6062B4Q38153026-E6C0317A-3C7F-45DE-947F-58CBB3D8D428Q39649198-14BEF8B8-77F7-4674-B342-C627A142CC54Q40328987-A46EC948-20C4-40DD-8097-58308636DFD9Q41370010-570DDC48-23FF-43BC-983D-3DCF2633F44EQ41519917-E3C81CAA-444E-401A-935F-D9F0937FA9EEQ41813144-5F8FFD1F-919F-4C33-9A45-56A3CE8C7092Q41837816-6BAD7BFE-8A45-40FA-BE70-BC94772BB298Q42841046-9CB796DF-D976-4137-9B08-E41439FE8C72Q42843026-8D6D91B6-AB2D-4F0B-9795-4E7FC2B1ED78Q44703131-5E8E87CD-AC76-47F0-9CF0-709688E50A56Q45823791-66170DFC-5A28-456B-8E1C-FE3D7D54A316Q46642909-3F97FC44-6719-4577-BB16-A272C73D85D4Q47246413-E469610F-4CFC-48E8-AEA1-5FF6EAF4F767Q55081917-2CD5F9FB-E512-46C4-942C-95B11B662A57
P2860
Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年学术文章
@wuu
1966年学术文章
@zh
1966年学术文章
@zh-cn
1966年学术文章
@zh-hans
1966年学术文章
@zh-my
1966年学术文章
@zh-sg
1966年學術文章
@yue
1966年學術文章
@zh-hant
name
Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
@en
Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
@nl
type
label
Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
@en
Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
@nl
prefLabel
Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
@en
Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
@nl
P1476
Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
@en
P2093
Goldsmith RS
P356
10.1056/NEJM196601062740101
P407
P577
1966-01-01T00:00:00Z